335 related articles for article (PubMed ID: 35902184)
1. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
Fang F; Tse B; Pavenski K
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
3. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
4. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.
de Bruijn S; Maes MB; De Waele L; Vanhoorelbeke K; Gadisseur A
J Thromb Haemost; 2021 Aug; 19(8):2014-2018. PubMed ID: 34105244
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
Schieppati F; Russo L; Gamba S; Galimberti E; Giaccherini C; Tartari CJ; Bolognini S; Verzeroli C; Ticozzi C; Barcella L; Marchetti M; Falanga A
Thromb Haemost; 2023 Oct; 123(10):945-954. PubMed ID: 37172940
[TBL] [Abstract][Full Text] [Related]
6. Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study.
Giuffrida G; Markovic U; Condorelli A; Calagna M; Grasso S; Duminuco A; Riccobene C; Pelle AC; Zanghi G; Di Raimondo F
Haematologica; 2022 Nov; 107(11):2661-2666. PubMed ID: 35511612
[TBL] [Abstract][Full Text] [Related]
7. Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab.
Laverdure E; Sperlich C; Fox S
J Thromb Haemost; 2022 Jul; 20(7):1696-1698. PubMed ID: 35510743
[TBL] [Abstract][Full Text] [Related]
8. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Tse B; Buchholz M; Pavenski K
Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
[TBL] [Abstract][Full Text] [Related]
9. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.
Buetler VA; Agbariah N; Schild DP; Liechti FD; Wieland A; Andina N; Hammann F; Kremer Hovinga JA
Front Med (Lausanne); 2022; 9():890661. PubMed ID: 35655852
[TBL] [Abstract][Full Text] [Related]
10. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review.
Kornowski Cohen M; Sheena L; Shafir Y; Yahalom V; Gafter-Gvili A; Spectre G
Acta Haematol; 2021; 144(6):678-682. PubMed ID: 33895748
[TBL] [Abstract][Full Text] [Related]
11. Treating thrombotic thrombocytopenic purpura without plasma exchange during the COVID-19 pandemic. A case report and a brief literature review.
Galindo-Calvillo CD; Rodríguez-Roque CS; Gómez-De León A; Tarín-Arzaga L; Gómez-Almaguer D
Transfus Apher Sci; 2021 Jun; 60(3):103107. PubMed ID: 33714651
[TBL] [Abstract][Full Text] [Related]
12. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D
J Thromb Haemost; 2021 Sep; 19(9):2314-2317. PubMed ID: 34105247
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
Vorster L; Kirk SE; Muscal E; Despotovic JM; Cohen CT; Sartain SE
Pediatr Blood Cancer; 2022 Jun; 69(6):e29681. PubMed ID: 35373880
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
Waqar SHB; Khan AA; Memon S
Int J Hematol; 2021 Nov; 114(5):626-629. PubMed ID: 34264514
[TBL] [Abstract][Full Text] [Related]
15. The standard of care for immune thrombotic thrombocytopenic purpura today.
Zheng XL
J Thromb Haemost; 2021 Aug; 19(8):1864-1871. PubMed ID: 34060225
[TBL] [Abstract][Full Text] [Related]
16. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.
Seguí IG; Mingot Castellano ME; Izquierdo CP; de la Rubia J
Expert Rev Hematol; 2024; 17(1-3):9-25. PubMed ID: 38353182
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
[TBL] [Abstract][Full Text] [Related]
18. Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura.
Gómez-Seguí I; Pascual Izquierdo C; de la Rubia Comos J
Expert Rev Hematol; 2021 Aug; 14(8):707-719. PubMed ID: 34275393
[TBL] [Abstract][Full Text] [Related]
19. Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Capecchi M; De Leo P; Abbattista M; Mancini I; Agosti P; Biganzoli M; Suffritti C; Ferrari B; Lecchi A; La Marca S; Padovan L; Scalambrino E; Clerici M; Tripodi A; Artoni A; Gualtierotti R; Peyvandi F
Haematologica; 2023 Nov; 108(11):3152-3155. PubMed ID: 36951158
[No Abstract] [Full Text] [Related]
20. Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.
Deucher W; Sukumar S; Cataland SR
Res Pract Thromb Haemost; 2022 Jan; 6(1):e12658. PubMed ID: 35155977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
